Tencent, a Chinese multinational investment holding conglomerate, and Merck KGaA, a German-based pharmaceutical, life sciences and technology company, are collaborating to increase disease awareness and provide more accessible healthcare services via digital platforms in China by leveraging AI and big data.

Accuray Asia Limited, a subsidiary of Sunnyvale, California-based Accuray, has entered into a joint venture with CNNC High Energy Equipment, a subsidiary of Tianjin, China-based China Isotope and Radiation Corporation (CIRC), to sell radiation oncology systems throughout China. 

The implementation of digital breast tomosynthesis (DBT) at eight radiology facilities in Vermont led to lower recall rates than full-field digital mammography (FFDM) alone, according to a new study published in the American Journal of Roentgenology. However, the authors observed no improvements in cancer detection rates.

Five major pharmaceutical companies could each lose $500 million or more in revenue per year if a proposal from the Trump administration to reimburse Medicare Part B drugs based on an international pricing index (IPI) is finalized.

The Radiological Society of North America (RSNA) estimates that RSNA 2018’s economic impact on the city of Chicago was $160 million. This is up from the society’s estimate that RSNA 2017 made an economic impact of $130 million on the Windy City.

Hospitals are now conducting wealth screenings with software that culls public data to see which patients are most likely to donate to the healthcare organization, The New York Times reported. The practice is increasingly common across hospitals, particularly large systems.

Providing free lung cancer screening with low-dose CT (LDCT) clearly helps patients, but it can also lead to financial benefits for healthcare providers, according to a study published in the Annals of Thoracic Surgery.

Deal volumes broke records in 2018 across the health services sector, and deal activity is likely to remain high in 2019 thanks to a number of positive market factors, according to PwC’s latest health services deals insights.